Company intelligence / Profile preview

Ponto Ventures

Manhattan Beach, California, United Statesbiospace.com ↗

Ownership: Private
Development stage: Other

Overview

Ponto Ventures LLC is a consulting and business development firm that entered into an agreement with RespireRx Pharmaceuticals Inc. in December 2023. Under this agreement, Will Clodfelter from Ponto Ventures serves as RespireRx’s Senior Vice President of Business Development on a part-time basis, focusing initially on the lead asset dronabinol for ResolutionRx Ltd., an Australian subsidiary of RespireRx. There is no evidence that Ponto Ventures develops its own drugs or technologies.

Industry: Consulting

Partnerships

RespireRx Pharmaceuticals Inc.

Beyond the preview

Go deeper on Ponto Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ponto Ventures.

Explore the full profile